Youssef Zeidan, MD, PhD: Expert Perspective on Radiotherapy and Treatment-Related Cardiotoxicity in Breast Cancer

Posted: Thursday, December 2, 2021

Youssef Zeidan, MD, PhD, of Florida International University and the Lynn Cancer Institute, discusses the ways in which radiotherapy has improved to reduce cardiotoxicity in patients treated with trastuzumab for HER2-positive breast cancer.